| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 05/06/2008 | CA2239694C Indane dimer compounds and their pharmaceutical use |
| 05/02/2008 | WO2008050168A1 New sulfonamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008050125A1 Compounds and uses thereof |
| 05/02/2008 | WO2008049595A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/02/2008 | CA2667507A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 04/29/2008 | US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | US20080096942 Beta-secretase inhibitors; use in treating Alzheimer's disease; for example, N-{(1S,2R)-1-[3-(cyclohexylmethyl)benzyl]-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}acetamide hydrochloride |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096934 N-[4-((S)-2-Propylamino-propyl)-phenyl]-4-trifluoromethoxy-benzenesulfonamide; Dipropyl-{2-[4-(4-trifluoromethoxy-benzenesulfonylmethyl)-phenyl]-ethyl}-dipropyl-amine salt, psychological, nervous system disorders such as schizophernia, bipolar, dyskinesias, tourette syndrome, depression, sleep disorder |
| 04/24/2008 | US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia |
| 04/23/2008 | EP1912935A2 Hiv reverse transcriptase inhibitors |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN100383116C Methoximinophenylacetic acid amides |
| 04/23/2008 | CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361782 Less toxic and less bioaccumulative than longer chain perfluorinated groups; for polymerizable water- and oil-repellent acrylic resins |
| 04/22/2008 | US7361765 resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/17/2008 | WO2008045671A1 Matrix metalloprotease inhibitors |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090788 Chemical Compounds |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/16/2008 | EP1911751A1 Amide derivative and pesticide containing such compound |
| 04/16/2008 | EP1911748A1 Method for producing substituted phenylsulfonyl ureas from sulfohalogenides |
| 04/16/2008 | EP1910281A1 Stable aqueous dispersions of colour developer |
| 04/16/2008 | EP1910280A2 Process of sulfonating 4-aminobenzonitriles |
| 04/16/2008 | EP1529240A4 Electrolytes for electrooptic devices comprising ionic liquids |
| 04/16/2008 | EP1373228B1 Substituted fluoroalcoxyphenylsulfonylurea |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | US7358398 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/10/2008 | WO2008040947A2 Soluble diazoalkane precursors |
| 04/10/2008 | WO2008040934A1 Hdac inhibitors |
| 04/10/2008 | WO2008021804A3 Therapeutic amides and related compounds |
| 04/10/2008 | US20080085928 such as N,N'-[hexane-1,6-diylbis(iminocarbonyl)]bis(3-chlorobenzenesulfonamide), used as Fructose-1,6-bisphosphatase inhibitors; metabolic disorders such as diabetes |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | CA2665428A1 Hdac inhibitors |
| 04/09/2008 | EP1907357A1 Aniline sulfonamide derivatives and their uses |
| 04/09/2008 | EP1907356A2 Process for the preparation of sulfonamide derivatives |
| 04/09/2008 | CN101160286A Process for the preparation of ccr-2 antagonist |
| 04/09/2008 | CN101160285A Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 04/08/2008 | US7354942 Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 04/03/2008 | WO2008040000A2 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008038640A1 Method for producing salt of 4-sulfinylamino-1-cyclohexanecarboxylic acid |
| 04/03/2008 | WO2008037628A1 Sulfonamide derivatives |
| 04/03/2008 | US20080081930 hydrogenation catalysts comprising the reaction products of sulphonylated diamines with metal compounds, used for reduction of carbonyl compounds to the corresponding chiral alcohols and imines to the corresponding chiral amines |
| 04/03/2008 | US20080081926 Sulfonylaminobenzoic acid and salt |
| 04/03/2008 | DE102004011720B4 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 04/03/2008 | CA2664365A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | CA2664037A1 Sulfonamide derivatives |
| 04/02/2008 | EP1905758A1 Tamsulosin free base and recovery process thereof |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/01/2008 | US7351836 Antiinflammatory agents |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351742 Sulfonamide derivatives for the treatment of diseases |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | CA2218434C Fluorinated ionic sulfonylmethylides and sulfonylimides, preparation process and use as photoinitiators |
| 03/27/2008 | WO2008035677A1 Novel chlorofluorosulfonimide and method for producing the same |
| 03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
| 03/27/2008 | US20080076667 Substituted fluoroalkoxyphenylsulfonylureas |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | CN101148430A Preparation method for 4-sulfonamidophenylhydrazine hydrochloride |
| 03/26/2008 | CN100376591C Process for the preparation of anticonvulsant derivatives |
| 03/26/2008 | CN100376553C Full halothane sulfonic acid salts, preparation method and application |
| 03/26/2008 | CN100376516C Sulphonylation method and reagent useful for perhalogenated sulphanilide synthesis |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/25/2008 | US7348448 Substituted phenyl esters; dementia |
| 03/25/2008 | US7348356 enzyme inhibitor for preventing the formation of insoluble Amyloid beta and arresting the production of Amyloid beta; prevention or treatment of such diseases in which the enzyme is involved; compound including a N-alkyl cycloalkyl group |
| 03/25/2008 | US7348125 Optical information recording medium and novel immonium compound |
| 03/25/2008 | US7347954 containing a quaternary ammonium salt and an ionic liquid can be converted into a polymer without compromising the excellent properties of the ionic liquid; excellent safety and electrical conductivity |
| 03/20/2008 | US20080071113 Reacting trifluoromethanesulfonic anhydride with bicyclo(2.2.1)hept-5-en-2-yl)methanamine in presence of water and a base |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/19/2008 | EP1900759A2 Polymer production |
| 03/19/2008 | EP1900723A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 03/19/2008 | EP1805138B1 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor |
| 03/19/2008 | CN101146768A Method for producing sulfamate-carboxylate derivative |
| 03/19/2008 | CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345095 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | CA2225206C Aminophenyl ketone derivatives and a method for the preparation thereof |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008029810A1 Phenylguanidine derivative or salt thereof, and pest control agent containing them as active ingredient |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |